Evidence map›Paper›PMID 33391273›Full record

ArticleFrontiers in immunology2020

Specific Induction of Double Negative B Cells During Protective and Pathogenic Immune Responses.

Christoph Ruschil, Gisela Gabernet, Gildas Lepennetier, Simon Heumos, Miriam Kaminski, Zsuzsanna Hracsko, Martin Irmler, Johannes Beckers, Ulf Ziemann, Sven Nahnsen and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 2 countries.

Christoph RuschilDepartment of Neurology and Stroke, Eberhard-Karls University, Tübingen, Germany.
Gisela GabernetQuantitative Biology Center (QBiC), Eberhard-Karls University of Tübingen, Tübingen, Germany.
Gildas LepennetierDepartment of Neurology, Technische Universität München, Munich, Germany.
Simon HeumosQuantitative Biology Center (QBiC), Eberhard-Karls University of Tübingen, Tübingen, Germany.
Miriam KaminskiDepartment of Psychiatry and Psychotherapy, Charite Universitätsmedizin, Berlin, Germany.
Zsuzsanna HracskoDepartment of Internal Medicine 1, Universitätsklinikum Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
Martin IrmlerInstitute of Experimental Genetics, Helmholtz Zentrum München GmbH, Neuherberg, Germany.
Johannes BeckersInstitute of Experimental Genetics, Helmholtz Zentrum München GmbH, Neuherberg, Germany.
Ulf ZiemannDepartment of Neurology and Stroke, Eberhard-Karls University, Tübingen, Germany.
Sven NahnsenQuantitative Biology Center (QBiC), Eberhard-Karls University of Tübingen, Tübingen, Germany.
Gregory P OwensDepartment of Biochemistry and Molecular Genetics, University of Colorado, Aurora, CO, United States.
Jeffrey L BennettDepartment of Neurology, Programs in Neuroscience and Immunology University of Colorado School of Medicine, Aurora, CO, United States.
Bernhard HemmerDepartment of Neurology, Technische Universität München, Munich, Germany.
Markus C KowarikDepartment of Neurology and Stroke, Eberhard-Karls University, Tübingen, Germany.
University of Tübingen · DEHelmholtz Zentrum München · DECharité - Universitätsmedizin Berlin · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEHertie Institute for Clinical Brain Research · DEMunich Cluster for Systems Neurology · DETechnical University of Munich · DEUniversity of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · US

Funding

Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis OpticaR01EY022936 · NEI · UNIVERSITY OF COLORADO DENVER · PI BENNETT, JEFFREY L · 2013 to 2022
$3.8M
NEI NIH HHS R01 EY022936
6 · The paper itself

Abstract

Double negative (DN) (CD19

Indexed as

Cell ProliferationImmunogenicity, VaccineLymphocyte ActivationAdolescentAdultAgedAged, 80 and overAntibodies, ViralAntigens, CD19Antigens, CD20B-LymphocytesCase-Control StudiesCommunicable DiseasesEncephalitis Viruses, Tick-BorneFemaleHumansAntibodies, ViralAntigens, CD19Antigens, CD20CD19 molecule, humanInfluenza VaccinesTumor Necrosis Factor Receptor Superfamily, Member 7Viral Vaccinesautoimmune disordersB cellsdouble negative B cellsinfluenza vaccinationneuromyelitis optica spectrum disorderTBE vaccinationvaccination

Identifiers

PMID33391273
PMCPMC7775384
OpenAlexW3113737607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.